Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Mar 2021 for Neos Therapeutics, Inc..
Insider track record
Disclosed buys
6
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
6
Positive at T+90
100%
Median T+90
+49.4%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +117.3%Entry US$2,968.75 · Close at T+365 US$6,450.00
- +157.9%Entry US$2,506.25 · Close at T+365 US$6,462.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John M. Limongelli: trading record in brief
John M. Limongelli is a declared insider at 3 companies; the most frequent names are Adolor Corp, Neos Therapeutics, Inc. and Trevena Inc. Between 15 December 2009 and 19 March 2021, the trades on record add up to 20 filings.
Purchases make up the whole of the open-market record (6 purchases, €81k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 share grants and 6 option exercises.
The median purchase comes to €14k.
The record was last updated on 19 March 2021 with a transaction in Neos Therapeutics, Inc. The clock since the last published purchase (15 December 2014) now reads 4,330 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John M. Limongelli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
83,015 sharesCommon StockSEC:0001104659-21-039264:0
16,985 shares@ US$0.844100.0% of flowCommon StockSEC:0001104659-21-036713:0
100,000 shares0Common StockSEC:0001104659-20-029269:0
3,000 shares@ US$4.14Common StockSEC:0001209191-14-075433:0
Canonical exit: 12 Mar 2015 (T+90)
9,000 shares@ US$4.00Common StockSEC:0001209191-14-074274:0
Canonical exit: 10 Mar 2015 (T+90)
5,256 shares@ US$3.39Adolor Common Stock (ADLR)SEC:0001076167-11-000036:0
119,744 shares@ US$3.39Adolor Common Stock (ADLR)SEC:0001076167-11-000036:1
56,931 shares@ US$1.77Adolor Common Stock (ADLR)SEC:0001076167-11-000036:2
13,069 shares@ US$1.77Adolor Common Stock (ADLR)SEC:0001076167-11-000036:3
67,500 shares@ US$1.34Adolor Common Stock (ADLR)SEC:0001076167-11-000036:4
22,500 shares@ US$1.34Adolor Common Stock (ADLR)SEC:0001076167-11-000036:5
18,750 shares0Adolor Common Stock (ADLR)SEC:0001076167-11-000036:6
511,200 shares@ US$4.25Adolor Common Stock (ADLR)SEC:0001076167-11-000036:7
18,750 shares0Common StockSEC:0001076167-11-000020:0
13,190 shares@ US$1.90Common StockSEC:0001445234-11-000001:0
Canonical exit: 12 Sept 2011 (T+90)
3,010 shares@ US$1.80Common StockSEC:0001445234-11-000001:1
Canonical exit: 13 Sept 2011 (T+90)
13,190 shares@ US$1.90Common StockSEC:0001445234-11-000002:0
Canonical exit: 19 Sept 2011 (T+90)
3,010 shares@ US$1.80Common StockSEC:0001445234-11-000002:1
Canonical exit: 20 Sept 2011 (T+90)
112,500 shares0Common StockSEC:0001445234-10-000001:0
60,000 shares0Common StockSEC:0001076167-09-000030:0
20 of 20 declarations
